|
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
|
12 Months Ended |
135 Months Ended |
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2011
|
| Cash flows from operating activities: |
|
|
|
|
| Net loss |
$ (3,918) |
$ (2,419) |
$ (44,078) |
[1],[2] |
| Less - loss for the period from discontinued operations |
0 |
0 |
164 |
[1],[2] |
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
| Depreciation and amortization of deferred charges |
153 |
162 |
1,001 |
[1] |
| Severance pay, net |
(23) |
11 |
12 |
[1] |
| Accrued interest on loans |
3 |
0 |
451 |
[1] |
| Amortization of discount on short-term loans |
0 |
0 |
1,864 |
[1] |
| Change in fair value of options and warrants |
0 |
0 |
(795) |
[1] |
| Expenses related to shares and options granted to service providers |
449 |
96 |
21,486 |
[1] |
| Stock-based compensation related to options granted to employees |
1,135 |
388 |
6,821 |
[1] |
| Decrease (increase) in accounts receivable and prepaid expenses |
105 |
(400) |
(381) |
[1] |
| Increase (decrease) in trade payables and convertible note |
(63) |
45 |
717 |
[1] |
| Increase (decrease) in other accounts payable and accrued expenses |
(64) |
48 |
1,397 |
[1] |
| Erosion of restricted cash |
0 |
0 |
(6) |
[1] |
| Net cash used in continuing operating activities |
(2,223) |
(2,069) |
(11,347) |
[1] |
| Net cash used in discontinued operating activities |
0 |
0 |
(23) |
[1] |
| Total net cash used in operating activities |
(2,223) |
(2,069) |
(11,370) |
[1] |
| Cash flows from investing activities: |
|
|
|
|
| Purchase of property and equipment |
(48) |
(5) |
(1,133) |
[1] |
| Restricted cash |
0 |
0 |
6 |
[1] |
| Investment in lease deposit |
(16) |
6 |
(17) |
[1] |
| Net cash used in continuing investing activities |
(64) |
1 |
(1,144) |
[1] |
| Net cash used in discontinued investing activities |
0 |
0 |
(16) |
[1] |
| Total net cash provided by (used in) investing activities |
(64) |
1 |
(1,160) |
[1] |
| Cash flows from financing activities: |
|
|
|
|
| Proceeds from issuance of Common stock, net |
3,602 |
2,118 |
12,319 |
[1] |
| Proceeds from loans, notes and issuance of warrants, net |
0 |
0 |
2,061 |
[1] |
| Credit from bank |
0 |
(46) |
0 |
[1] |
| Proceeds from exercise of warrants and options |
515 |
88 |
631 |
[1] |
| Repayment of short-term loans |
0 |
0 |
(601) |
[1] |
| Net cash provided by continuing financing activities |
4,117 |
2,160 |
14,410 |
[1] |
| Net cash provided by discontinued financing activities |
0 |
0 |
43 |
[1] |
| Total net cash provided by financing activities |
4,117 |
2,160 |
14,453 |
[1] |
| Increase in cash and cash equivalents |
1,830 |
92 |
1,923 |
[1] |
| Cash and cash equivalents at the beginning of the period |
93 |
1 |
0 |
|
| Cash and cash equivalents at end of the period |
1,923 |
93 |
1,923 |
|
| Non-cash financing activities: |
|
|
|
|
| Conversion of convertible loan and convertible note to shares |
140 |
324 |
0 |
[1] |
| Conversion of other accounts payable to Common Stock |
24 |
487 |
0 |
[1] |
| Conversion of a trade payable to Common Stock |
$ 0 |
$ 200 |
$ 0 |
[1] |
|
|
|